These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21122390)

  • 1. [Treatment of recurrent malignant gliomas by surgery combined with recombinant adenovirus-p53 injection].
    Zhu JX; Li ZM; Geng FY; Fu Q; Guo CJ; Xiao YL; Zhang ZT; Li G
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):709-12. PubMed ID: 21122390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma.
    Li H; Alonso-Vanegas M; Colicos MA; Jung SS; Lochmuller H; Sadikot AF; Snipes GJ; Seth P; Karpati G; Nalbantoglu J
    Clin Cancer Res; 1999 Mar; 5(3):637-42. PubMed ID: 10100717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of recurrent malignant brain gliomas by surgical excision combined with biodegradable polymers of interstitial chemotherapy].
    Qi ST; Qiu BH
    Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):58-61. PubMed ID: 15059361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
    Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
    Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
    Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts.
    Song K; Cowan KH; Sinha BK
    Oncol Res; 1999; 11(3):153-9. PubMed ID: 10527075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner.
    Su ZZ; Lebedeva IV; Sarkar D; Gopalkrishnan RV; Sauane M; Sigmon C; Yacoub A; Valerie K; Dent P; Fisher PB
    Oncogene; 2003 Feb; 22(8):1164-80. PubMed ID: 12606943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma.
    Pan JJ; Zhang SW; Chen CB; Xiao SW; Sun Y; Liu CQ; Su X; Li DM; Xu G; Xu B; Lu YY
    J Clin Oncol; 2009 Feb; 27(5):799-804. PubMed ID: 19103729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas.
    Kong DS; Lee JI; Park K; Kim JH; Lim DH; Nam DH
    Cancer; 2008 May; 112(9):2046-51. PubMed ID: 18338759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AdDelta24 and the p53-expressing variant AdDelta24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy.
    Idema S; Lamfers ML; van Beusechem VW; Noske DP; Heukelom S; Moeniralm S; Gerritsen WR; Vandertop WP; Dirven CM
    J Gene Med; 2007 Dec; 9(12):1046-56. PubMed ID: 17966130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival.
    Harrow S; Papanastassiou V; Harland J; Mabbs R; Petty R; Fraser M; Hadley D; Patterson J; Brown SM; Rampling R
    Gene Ther; 2004 Nov; 11(22):1648-58. PubMed ID: 15334111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 enhances the Delta-24 conditionally replicative adenovirus anti-glioma effect.
    Mitlianga PG; Sioka C; Vartholomatos G; Goussia A; Polyzoidis K; Rao JS; Kyritsis AP
    Oncol Rep; 2006 Jan; 15(1):149-53. PubMed ID: 16328048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
    Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Zhu GY; Xu B
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):426-8. PubMed ID: 16188130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study.
    Immonen A; Vapalahti M; Tyynelä K; Hurskainen H; Sandmair A; Vanninen R; Langford G; Murray N; Ylä-Herttuala S
    Mol Ther; 2004 Nov; 10(5):967-72. PubMed ID: 15509514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of recombinant adenovirus p53 injection on laryngeal cancer: phase I clinical trial and follow up].
    Han DM; Huang ZG; Zhang W; Yu ZK; Wang Q; Ni X; Chen XH; Pan JH; Wang H
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2029-32. PubMed ID: 14703409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An experimental research on the combination treatment of sFLK-1 gene therapy combined with gamma knife].
    Chen J; Wang ZR; Li H; Wei YQ; Wang W; Zhu B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):708-11, 716. PubMed ID: 17037733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recombinant adenovirus p53 agent injection combined with radiotherapy in treatment of nasopharyngeal carcinoma: a phase II clinical trial].
    Chen CB; Pan JJ; Xu LY
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2033-5. PubMed ID: 14703410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of p53 gene change and serum antibody level in phase II clinical trial of ad p53 gene therapy].
    Zhao M; Xiao SW; Yang JX; Zhang SW; Lü YY
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3495-8. PubMed ID: 16686067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas.
    Schueller P; Micke O; Palkovic S; Schroeder J; Moustakis C; Bruns F; Schuck A; Wassmann H; Willich N
    Strahlenther Onkol; 2005 Aug; 181(8):500-6. PubMed ID: 16044217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.